FUTIBATINIB
Futibatinib 4 mg tablet, 35
FUTIBATINIB (15401N)
15401N
Manner of administration:Oral
Restriction (Streamlined authority code: 18828)
Indication: Locally advanced or metastatic cholangiocarcinoma
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 4 | Max qty units: 140 | # of repeats: 5 | DPMQ: $16,717.28 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lytgobi | |||||